CSIMarket
 


Anixa Biosciences Inc   (ANIX)
Other Ticker:  
 

Cumulative Anixa Biosciences Inc 's Leverage Ratio for Trailing Twelve Months Period

ANIX's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ANIX Leverage Ratio for Trailing Twelve Months Period

(Oct 31 2022)
IV. Quarter
(Jul 31 2022)
III. Quarter
(Apr 30 2022)
II. Quarter
(Jan 31 2022)
I. Quarter
(Oct 31 2021)
IV. Quarter
Y / Y Equity Growth -18.89 % -13.8 % -15.24 % 154.16 % 320.68 %
Y / Y Total Liabilities Growth 66.44 % 47.42 % -27.03 % 32.32 % 28.86 %
Leverage Ratio for Trailing Twelve Months Period 0.03 0.03 0.02 0.03 0.03
Total Ranking # 106 # 107 # 103 # 149 # 98
Seq. Equity Growth -8.76 % -1.59 % -5.52 % -4.39 % -3.03 %
Seq. Total Liabilities Growth 58.35 % 37.7 % -50.9 % 55.47 % 40.25 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite net new borrowings of 58.35% Anixa Biosciences Inc managed to unchange Leverage Ratio for Trailing Twelve Months Period in IV. Quarter to 0.03, below Anixa Biosciences Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 43 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Anixa Biosciences Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 106, from total ranking in previous quarter at 107.

What is Leverage Ratio?
Who are ANIX's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 44
Sector # 58
S&P 500 # 106


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
2.14 0.4 0.05
(Oct 31 2016)   (Apr 30 2022)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Oct 31 2022, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Trillium Therapeutics Inc   0.09 
Pepgen Inc   0.09 
Immunic Inc   0.09 
Immutep Limited  0.09 
Compass Pathways Plc  0.09 
Oncternal Therapeutics Inc   0.08 
Virpax Pharmaceuticals Inc   0.08 
Diffusion Pharmaceuticals Inc   0.08 
Rapt Therapeutics Inc   0.08 
Kezar Life Sciences Inc   0.08 
Satsuma Pharmaceuticals Inc   0.08 
Crinetics Pharmaceuticals Inc   0.08 
Janux Therapeutics Inc   0.08 
Spruce Biosciences Inc   0.08 
Synlogic Inc   0.08 
Salarius Pharmaceuticals inc   0.08 
Purple Biotech Ltd   0.08 
Pmv Pharmaceuticals Inc   0.08 
Hcw Biologics Inc   0.08 
Tff Pharmaceuticals Inc   0.08 
Tyme Technologies Inc.  0.07 
Reviva Pharmaceuticals Holdings Inc   0.07 
Cohbar Inc   0.07 
Xenetic Biosciences Inc   0.07 
Galecto Inc   0.07 
Graybug Vision Inc   0.07 
Bio path Holdings Inc  0.07 
Longboard Pharmaceuticals Inc   0.07 
Connect Biopharma Holdings Limited  0.07 
Sensei Biotherapeutics Inc   0.07 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FICO's Profile

Stock Price

FICO's Financials

Business Description

Fundamentals

Charts & Quotes

FICO's News

Suppliers

FICO's Competitors

Customers & Markets

Economic Indicators

FICO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071